Lobo-Sanahuja F, García I, Santamaría S, Barrantes J C
Oncology Department, Hospital Nacional de Niños, Costa Rica, San José, Costa Rica.
Med Pediatr Oncol. 1996 Mar;26(3):196-200. doi: 10.1002/(SICI)1096-911X(199603)26:3<196::AID-MPO9>3.0.CO;2-F.
Pulmonary blastoma (PB) is a rare primary malignancy of the lung, with about 54 cases reported in children. The tumor consists of mesenchymal and epithelial components resembling the fetal lung. It has been treated primarily with surgery and the effect of combination chemotherapy has not been systematically investigated. A 15-year-old girl with PB with metastases to bone and regional lymph node, and high levels of alphafetoprotein, is reported. A preoperative combination chemotherapy consisting of cisplatinum, etoposide alternating with iphosphamide with mesna, vincristine and epirubicine resulted in an objective response that permitted subsequent safe surgical excision of the primary tumor. This intensive combination chemotherapy should be tested in the management of advanced PB in children, as initial therapy as well as an adjuvant to surgery.
肺母细胞瘤(PB)是一种罕见的原发性肺恶性肿瘤,儿童病例报道约54例。该肿瘤由类似胎儿肺的间充质和上皮成分组成。其主要治疗方法为手术,联合化疗的效果尚未得到系统研究。本文报道了一名15岁患肺母细胞瘤且伴有骨和区域淋巴结转移以及甲胎蛋白水平升高的女孩。术前采用顺铂、依托泊苷交替联合异环磷酰胺加美司钠、长春新碱和表柔比星的化疗方案产生了客观反应,使得后续能够安全地手术切除原发肿瘤。这种强化联合化疗应作为初始治疗以及手术辅助治疗,在儿童晚期肺母细胞瘤的治疗中进行试验。